Relign

About Relign

Based in Silicon Valley, Relign Corporation is a medical technology firm focused on the arthroscopic surgery market. Founded in 2011, the company developed solutions to enhance surgical efficiency and surgeon control. A significant milestone was achieved in December 2016 when Relign received FDA 510(k) clearance for its flagship product. The company's growth was financed through several funding rounds, including a notable Series B round on June 15, 2018, which raised $30.1 million from investors like Synergy Ventures, UCSF Rosenman Institute, and Medical Technology Venture Partners. This culminated in the company's acquisition by the major medical device manufacturer Zimmer Biomet on November 12, 2020, marking a key portfolio enhancement for Zimmer Biomet in the sports medicine and ambulatory surgery center markets.

Relign's core business revolves around the design, manufacturing, and sale of advanced surgical systems for orthopedic and arthroscopic procedures. Its primary clients are orthopedic surgeons and medical facilities that perform minimally invasive joint surgeries. The company operates in the multi-billion-dollar sports medicine and arthroscopy market, generating revenue through the sale of its integrated surgical systems and the associated disposable devices.

The company's principal product is the Tricera™ Arthroscopic System, a platform that consolidates multiple surgical functions into a single, software-controlled unit. This system integrates tissue ablation and coagulation, soft tissue resection, bone cutting, and automated fluid management. A key component is the 3-in-1 Shaver device, which allows a surgeon to switch between soft tissue resection, bone burring, and coagulation without changing instruments intraoperatively. This all-in-one approach is designed to save time, reduce the need for repeated instrument triangulation, and minimize iatrogenic soft tissue trauma during procedures. The system also features the Veriflow™ fluid management technology, which is incorporated directly into the main controller to automatically and accurately manage pressure within the joint.